Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
AstraZeneca
Deloitte
Colorcon
McKinsey
Merck
US Department of Justice
Teva
Cantor Fitzgerald

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ASPIRIN AND DIPYRIDAMOLE

« Back to Dashboard

Clinical Trials for Aspirin And Dipyridamole

Trial ID Title Status Sponsor Phase Summary
NCT00000463 Post Coronary Artery Bypass Graft (CABG) Study Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 To determine the relative effectiveness of moderate versus more aggressive lipid lowering, and of low dose anticoagulation versus placebo, in delaying saphenous vein coronary bypass graft atherosclerosis and preventing occlusion of saphenous grafts of patients with saphenous vein coronary bypass grafts placed 1 to 11 years previously.
NCT00000496 Platelet Drug Trial in Coronary Disease Progression Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 To determine the effectiveness of the platelet inhibitor drugs dipyridamole and aspirin in reducing the angiographic progression of coronary artery disease over a five-year period and to test the predictive value of the platelet survival half-life in identifying patients with more rapid progression of coronary disease and development of its complications.
NCT00000510 Platelet-Inhibitor Drug Trial in Coronary Angioplasty Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 To determine the effectiveness of dipyridamole and aspirin in prevention of restenosis of the dilated lesion in patients who had undergone percutaneous transluminal coronary angioplasty (PTCA). Secondary aims were to determine the effectiveness of platelet inhibitor therapy in reducing the incidence of coronary events and the severity and incidence of angina.
NCT00000527 Recurrent Carotid Stenosis Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 2 To determine whether recurrent stenosis following carotid endarterectomy could be reduced by pre- and post-operative oral administration of platelet-inhibiting drugs.
NCT00000527 Recurrent Carotid Stenosis Completed Emory University Phase 2 To determine whether recurrent stenosis following carotid endarterectomy could be reduced by pre- and post-operative oral administration of platelet-inhibiting drugs.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Aspirin And Dipyridamole

Condition Name

Condition Name for Aspirin And Dipyridamole
Intervention Trials
Heart Diseases 4
Cardiovascular Diseases 4
Stroke 4
Myocardial Ischemia 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Aspirin And Dipyridamole
Intervention Trials
Cardiovascular Diseases 5
Coronary Artery Disease 4
Stroke 4
Myocardial Ischemia 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Aspirin And Dipyridamole

Trials by Country

Trials by Country for Aspirin And Dipyridamole
Location Trials
United States 48
Canada 9
Italy 5
Australia 4
United Kingdom 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Aspirin And Dipyridamole
Location Trials
Tennessee 2
Oklahoma 2
New York 2
Minnesota 2
Pennsylvania 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Aspirin And Dipyridamole

Clinical Trial Phase

Clinical Trial Phase for Aspirin And Dipyridamole
Clinical Trial Phase Trials
Phase 4 7
Phase 3 7
Phase 2/Phase 3 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Aspirin And Dipyridamole
Clinical Trial Phase Trials
Completed 14
Recruiting 4
Terminated 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Aspirin And Dipyridamole

Sponsor Name

Sponsor Name for Aspirin And Dipyridamole
Sponsor Trials
Boehringer Ingelheim 5
National Heart, Lung, and Blood Institute (NHLBI) 4
Yangzhou University 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Aspirin And Dipyridamole
Sponsor Trials
Other 21
Industry 8
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Colorcon
Fish and Richardson
Johnson and Johnson
Julphar
Accenture
Moodys
Covington
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.